Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-9098
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease ; volume:31 ; number:4 ; day:18 ; month:8 ; year:2020 ; pages:813-821 ; date:12.2019
The Egyptian Journal of Internal Medicine ; 31, Heft 4 (18.8.2020), 813-821, 12.2019
- Urheber
-
Elarbagy, Ahmed R.
Yassein, Yassein S.
Emara, Mahmoud M.
Sonbol, Ahmed A.
Zorkaney, Khaled M.
El Deen, Amera A. Sharaf
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.4103/ejim.ejim_34_19
- URN
-
urn:nbn:de:101:1-2021060508461276253758
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elarbagy, Ahmed R.
- Yassein, Yassein S.
- Emara, Mahmoud M.
- Sonbol, Ahmed A.
- Zorkaney, Khaled M.
- El Deen, Amera A. Sharaf
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
Serum sclerostin levels in osteoporotic fracture patients
Protective effects of spironolactone on vascular calcification in chronic kidney disease
Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation
"Vascular calcification in chronic kidney disease: vitamin K deficiency and new mediators"
Molecular mechanisms of vascular calcification
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
BRCC36 regulates β-catenin ubiquitination to alleviate vascular calcification in chronic kidney disease
Correction to: Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
Serum sclerostin levels in osteoporotic fracture patients
Protective effects of spironolactone on vascular calcification in chronic kidney disease
Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation
"Vascular calcification in chronic kidney disease: vitamin K deficiency and new mediators"
Molecular mechanisms of vascular calcification
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
BRCC36 regulates β-catenin ubiquitination to alleviate vascular calcification in chronic kidney disease
Correction to: Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
Serum sclerostin levels in osteoporotic fracture patients
Protective effects of spironolactone on vascular calcification in chronic kidney disease
Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation
"Vascular calcification in chronic kidney disease: vitamin K deficiency and new mediators"
Molecular mechanisms of vascular calcification
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5